semaglutide ban 2025 Weight loss wonder drugs Ozempic and Wegovy could be banned by the World Anti-Doping Agency (WADA) prior to the Los Angeles Olympic Games, as concern over athletes abusing anti-obesity drugs grows. That's ESC 2025: evidence of semaglutide

PubMed American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (Adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists

Abdominal pain and dyspepsia are reported in 6-10% of patients

In one 68-week trial with over 1,900 obese participants, those who took Wegovy lost an average of 15% of their initial body weight compared to only 2.4% weight loss in the placebo group

#PCOS #Infertility #GLP1Agonists #HealthyPregnancy #WomenHealth #PCOSAwareness #FertilityJourney #HopeForPCOSWarriors Minis, E., & S

Some days, eating enough can feel harder

This may result in faster weight reduction among gym-goers